
A JMIR article examines the disconnect between AI legal requirements and actual patient comprehension in medical imaging and diagnostics.
Key Details
- 1The EU AI Act sets legal expectations for transparency in high-risk AI used in medical imaging and diagnostics.
- 2Current AI models are often too complex for meaningful, patient-facing explanations, creating an interpretability-accuracy trade-off.
- 3Automation bias can skew clinician decisions towards flawed AI outputs.
- 4A large proportion (22%–58%) of EU citizens struggle to understand health information, complicating AI explainability.
- 5The article calls for co-design with patients, institutional support, and standards for digital health literacy.
- 6Existing regulations alone are insufficient for delivering actionable explanations to patients.
Why It Matters

Source
EurekAlert
Related News

AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.

AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.

AI-Enhanced Imaging Breaks Barriers in Complex Media for Biomedical Use
Researchers developed a physics-based machine learning imaging system that enhances visibility through complex media, holding promise for biomedical imaging.